CME Financials CME Group

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Oct 25, 2026, 10:25 UTC Overview →

Growth & profitability

Revenue has grown 6.0% per year over the past 5 years.
Net income has grown faster than revenue (14.1% vs 6.0% per year).
Operating margin has expanded, at 64.9% in the latest year.
Free cash flow has grown 10.7% per year over the past 5 years.

Financial health

Operating income covered interest expense 24× in the latest year, up from 16× 5 years ago.

Shareholder returns

Dividends have been paid for 15 consecutive years, consuming 96.6% of earnings and 93.8% of free cash flow.
The dividend has grown 13.3% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$6.5B	$4.1B	0.0%	64.9%	14.2%	2.1%	$4.2B	—	$4.4B
2024	$6.1B	$3.5B	0.0%	64.1%	13.3%	2.6%	$3.6B	—	$2.9B
2023	$5.6B	$3.2B	0.0%	61.6%	12.1%	2.5%	$3.4B	—	$2.9B
2022	$5.0B	$2.7B	0.0%	60.1%	10.0%	1.5%	$3.0B	—	$2.7B
2021	$4.7B	$2.6B	0.0%	56.4%	9.6%	1.3%	$2.3B	—	$2.8B
2020	$4.9B	$2.1B	0.0%	54.0%	8.0%	1.7%	$2.5B	—	$1.6B
2019	$4.9B	$2.1B	0.0%	53.2%	8.1%	2.8%	$2.4B	—	$1.6B
2018	$4.3B	$2.0B	0.0%	60.5%	7.6%	2.5%	$2.3B	—	$1.4B
2017	$3.6B	$4.1B	0.0%	63.4%	18.1%	5.4%	$1.7B	—	$1.9B
2016	$3.6B	$1.5B	0.0%	61.2%	7.5%	2.2%	$1.6B	—	$1.9B
2015	$3.3B	$1.2B	0.0%	59.8%	6.1%	1.9%	$1.4B	—	$1.7B
2014	$3.1B	$1.1B	0.0%	56.8%	5.4%	1.6%	$1.2B	—	$1.4B
2013	$2.9B	$977M	0.0%	55.8%	4.6%	1.8%	$1.2B	—	$2.5B
2012	$2.9B	$896M	0.0%	58.1%	4.2%	2.3%	$1.1B	—	$1.6B
2011	$3.3B	$1.8B	0.0%	61.6%	8.4%	4.4%	$1.2B	—	$1.0B

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Sep '26	$1.7B	$1.0B	0.0%	65.7%	3.9%	0.5%	$1.1B	—	$2.2B
Jun '26	$1.7B	$1.0B	0.0%	64.9%	3.9%	0.5%	$924M	—	$2.1B
Mar '26	$1.9B	—	0.0%	69.7%	0.0%	0.0%	$1.2B	—	$2.4B
Dec '25	$1.6B	—	0.0%	61.8%	0.0%	0.0%	$1.1B	—	$4.4B
Sep '25	$1.5B	$908M	0.0%	63.3%	3.2%	0.5%	$950M	—	$2.4B
Jun '25	$1.7B	$1.0B	0.0%	66.7%	3.7%	0.6%	$1.0B	—	$2.0B
Mar '25	$1.6B	—	0.0%	67.5%	0.0%	0.0%	$1.1B	—	$1.4B
Dec '24	$1.5B	—	0.0%	62.1%	0.0%	0.0%	$992M	—	$2.9B
Sep '24	$1.6B	—	0.0%	64.6%	0.0%	0.0%	$973M	—	$2.3B
Jun '24	$1.5B	—	0.0%	65.3%	0.0%	0.0%	$759M	—	$1.8B
Mar '24	$1.5B	—	0.0%	64.5%	0.0%	0.0%	$873M	—	$1.4B
Dec '23	$1.4B	—	0.0%	60.0%	0.0%	0.0%	$1.0B	—	$2.9B
Sep '23	$1.3B	—	0.0%	61.3%	0.0%	0.0%	$837M	—	$2.3B
Jun '23	$1.4B	—	0.0%	61.7%	0.0%	0.0%	$630M	—	$1.9B
Mar '23	$1.4B	—	0.0%	63.4%	0.0%	0.0%	$887M	—	$1.6B
Dec '22	$1.2B	$638M	0.0%	55.3%	2.4%	0.4%	$957M	—	$2.7B
Sep '22	$1.2B	$680M	0.0%	60.2%	2.4%	0.4%	$634M	—	$2.1B
Jun '22	$1.2B	$663M	0.0%	60.6%	2.4%	0.4%	$600M	—	$1.9B
Mar '22	$1.3B	$711M	0.0%	63.8%	2.6%	0.3%	$776M	—	$2.0B
Dec '21	$1.1B	$625M	0.0%	55.1%	2.3%	0.3%	$641M	—	$2.8B

Valuation over time

How the market has priced CME against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has risen from 25.5× (Mar '23) to 26.9× (Nov '26).
The price-to-sales ratio has risen from 13.7× (Mar '23) to 16.8× (Nov '26).
The dividend yield has fallen from 3.8% (Mar '23) to 3.6% (Nov '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is CME growing its revenue and profit?

Over the past 5 years, CME Group's revenue has grown 6.0% per year, and net income grown 14.1% per year. These are computed facts, not advice.

How much debt does CME have?

As of FY2025, CME Group reported — of total debt against $4.4B of cash; operating income covered interest expense 24×.

What is CME's profit margin?

In FY2025, gross margin was —, operating margin 64.9%, and net margin 62.5%.

What is CME's P/E ratio?

CME Group's P/E (TTM) is 26.92 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the CME stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 26.9× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.